LSE - Delayed Quote GBp
Abingdon Health Plc (ABDX.L)
As of 11:30 AM GMT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Christopher William Hand | Executive Chairman | 77k | -- | 1961 |
| Mr. Chris Henry Francis Yates | CEO, Company Secretary & Director | 287k | -- | 1974 |
| Laura Towse | Group Financial Controller | -- | -- | -- |
| Mr. Mark Jones | Chief Operating Officer | -- | -- | -- |
Abingdon Health Plc
York Biotech Campus
Sand Hutton
York, YO41 1LZ
United Kingdom
- Sector:?
- Healthcare
- Industry:? Diagnostics & Research
- Full Time Employees:?
- 84
Description
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Corporate Governance
Abingdon Health Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
October 9, 2024 at 7:30 AM UTC - October 14, 2024 at 7:30 AM UTC
Abingdon Health Plc Earnings Date
Recent Events
Recent Events Information Not Available